Literature DB >> 25422322

Hypochlorous acid generated by neutrophils inactivates ADAMTS13: an oxidative mechanism for regulating ADAMTS13 proteolytic activity during inflammation.

Yi Wang1, Junmei Chen1, Minhua Ling1, José A López2, Dominic W Chung3, Xiaoyun Fu4.   

Abstract

ADAMTS13 is a plasma metalloproteinase that cleaves large multimeric forms of von Willebrand factor (VWF) to smaller, less adhesive forms. ADAMTS13 activity is reduced in systemic inflammatory syndromes, but the cause is unknown. Here, we examined whether neutrophil-derived oxidants can regulate ADAMTS13 activity. We exposed ADAMTS13 to hypochlorous acid (HOCl), produced by a myeloperoxidase-H2O2-Cl(-) system, and determined its residual proteolytic activity using both a VWF A2 peptide substrate and multimeric plasma VWF. Treatment with 25 nm myeloperoxidase plus 50 μm H2O2 reduced ADAMTS13 activity by >85%. Using mass spectrometry, we demonstrated that Met(249), Met(331), and Met(496) in important functional domains of ADAMTS13 were oxidized to methionine sulfoxide in an HOCl concentration-dependent manner. The loss of enzyme activity correlated with the extent of oxidation of these residues. These Met residues were also oxidized in ADAMTS13 exposed to activated human neutrophils, accompanied by reduced enzyme activity. ADAMTS13 treated with either neutrophil elastase or plasmin was inhibited to a lesser extent, especially in the presence of plasma. These observations suggest that oxidation could be an important mechanism for ADAMTS13 inactivation during inflammation and contribute to the prothrombotic tendency associated with inflammation.
© 2015 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  ADAMTS13; HOCl; Inflammation; Methionine Oxidation; Myeloperoxidase; Neutrophil; Thrombosis

Mesh:

Substances:

Year:  2014        PMID: 25422322      PMCID: PMC4340389          DOI: 10.1074/jbc.M114.599084

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  50 in total

1.  The proximal carboxyl-terminal domains of ADAMTS13 determine substrate specificity and are all required for cleavage of von Willebrand factor.

Authors:  Jihui Ai; Paula Smith; Shuwei Wang; Ping Zhang; X Long Zheng
Journal:  J Biol Chem       Date:  2005-06-23       Impact factor: 5.157

2.  Acquired ADAMTS-13 deficiency in pediatric patients with severe sepsis.

Authors:  Trung C Nguyen; Anne Liu; Li Liu; Chalmette Ball; Hiuwan Choi; William S May; Khatira Aboulfatova; Angela L Bergeron; Jing-Fei Dong
Journal:  Haematologica       Date:  2007-01       Impact factor: 9.941

3.  Inactivation of ADAMTS13 by plasmin as a potential cause of thrombotic thrombocytopenic purpura.

Authors:  H B Feys; N Vandeputte; R Palla; F Peyvandi; K Peerlinck; H Deckmyn; H R Lijnen; K Vanhoorelbeke
Journal:  J Thromb Haemost       Date:  2010-09       Impact factor: 5.824

4.  A rapid enzyme-linked assay for ADAMTS-13.

Authors:  J-J Wu; K Fujikawa; E C Lian; B A McMullen; J D Kulman; D W Chung
Journal:  J Thromb Haemost       Date:  2006-01       Impact factor: 5.824

5.  Mutations in a member of the ADAMTS gene family cause thrombotic thrombocytopenic purpura.

Authors:  G G Levy; W C Nichols; E C Lian; T Foroud; J N McClintick; B M McGee; A Y Yang; D R Siemieniak; K R Stark; R Gruppo; R Sarode; S B Shurin; V Chandrasekaran; S P Stabler; H Sabio; E E Bouhassira; J D Upshaw; D Ginsburg; H M Tsai
Journal:  Nature       Date:  2001-10-04       Impact factor: 49.962

6.  Characterization of a core binding site for ADAMTS-13 in the A2 domain of von Willebrand factor.

Authors:  Jing-Jiang Wu; Kazuo Fujikawa; Brad A McMullen; Dominic W Chung
Journal:  Proc Natl Acad Sci U S A       Date:  2006-11-22       Impact factor: 11.205

Review 7.  Hypochlorite-induced oxidation of amino acids, peptides and proteins.

Authors:  C L Hawkins; D I Pattison; M J Davies
Journal:  Amino Acids       Date:  2003-07-29       Impact factor: 3.520

8.  Oxidative modification of von Willebrand factor by neutrophil oxidants inhibits its cleavage by ADAMTS13.

Authors:  Junmei Chen; Xiaoyun Fu; Yi Wang; Minhua Ling; Brad McMullen; John Kulman; Dominic W Chung; José A López
Journal:  Blood       Date:  2009-10-07       Impact factor: 22.113

9.  Plasma ADAMTS13 activity parallels the APACHE II score, reflecting an early prognostic indicator for patients with severe acute pancreatitis.

Authors:  Chie Morioka; Masahito Uemura; Tomomi Matsuyama; Masanori Matsumoto; Seiji Kato; Masatoshi Ishikawa; Hiromichi Ishizashi; Masao Fujimoto; Masayoshi Sawai; Motoyuki Yoshida; Akira Mitoro; Junichi Yamao; Tatsuhiro Tsujimoto; Hitoshi Yoshiji; Yasuyuki Urizono; Michiaki Hata; Kenji Nishino; Kazuo Okuchi; Yoshihiro Fujimura; Hiroshi Fukui
Journal:  Scand J Gastroenterol       Date:  2008       Impact factor: 2.423

10.  Severe Plasmodium falciparum malaria is associated with circulating ultra-large von Willebrand multimers and ADAMTS13 inhibition.

Authors:  Deirdre Larkin; Bas de Laat; P Vince Jenkins; James Bunn; Alister G Craig; Virginie Terraube; Roger J S Preston; Cynthia Donkor; George E Grau; Jan A van Mourik; James S O'Donnell
Journal:  PLoS Pathog       Date:  2009-03-20       Impact factor: 6.823

View more
  26 in total

Review 1.  Regulation of thrombosis and vascular function by protein methionine oxidation.

Authors:  Sean X Gu; Jeff W Stevens; Steven R Lentz
Journal:  Blood       Date:  2015-04-21       Impact factor: 22.113

2.  Assessment of Novel Antioxidant Therapy in Atherosclerosis by Contrast Ultrasound Molecular Imaging.

Authors:  Tamara Atkinson; William Packwood; Aris Xie; Sherry Liang; Yue Qi; Zaverio Ruggeri; Jose Lopez; Brian P Davidson; Jonathan R Lindner
Journal:  J Am Soc Echocardiogr       Date:  2018-09-11       Impact factor: 5.251

3.  Molecular Imaging of VWF (von Willebrand Factor) and Platelet Adhesion in Postischemic Impaired Microvascular Reflow.

Authors:  Koya Ozawa; William Packwood; Oleg Varlamov; Yue Qi; Aris Xie; Melinda D Wu; Zaverio Ruggeri; Jose A López; Jonathan R Lindner
Journal:  Circ Cardiovasc Imaging       Date:  2018-11       Impact factor: 7.792

4.  Identification of oxidant susceptible proteins in Salmonella Typhimurium.

Authors:  Shekhar Apoorva; Pranatee Behera; Basavaraj Sajjanar; Manish Mahawar
Journal:  Mol Biol Rep       Date:  2020-02-19       Impact factor: 2.316

Review 5.  Platelets and von Willebrand factor in atherogenesis.

Authors:  Melinda D Wu; Tamara M Atkinson; Jonathan R Lindner
Journal:  Blood       Date:  2017-02-07       Impact factor: 22.113

Review 6.  Pathophysiology of thrombotic thrombocytopenic purpura.

Authors:  J Evan Sadler
Journal:  Blood       Date:  2017-08-02       Impact factor: 22.113

7.  ADAMTS13 Retards Progression of Diabetic Nephropathy by Inhibiting Intrarenal Thrombosis in Mice.

Authors:  Nirav Dhanesha; Prakash Doddapattar; Mehul R Chorawala; Manasa K Nayak; Koichi Kokame; Janice M Staber; Steven R Lentz; Anil K Chauhan
Journal:  Arterioscler Thromb Vasc Biol       Date:  2017-05-11       Impact factor: 8.311

Review 8.  Diverse activities of von Willebrand factor in traumatic brain injury and associated coagulopathy.

Authors:  Xin Xu; Rosemary Kozar; Jianning Zhang; Jing-Fei Dong
Journal:  J Thromb Haemost       Date:  2020-10-06       Impact factor: 5.824

9.  Effects of Gut Microbiome on Carcinogenic DNA Damage.

Authors:  Yun-Chung Hsiao; Chih-Wei Liu; Liang Chi; Yifei Yang; Kun Lu
Journal:  Chem Res Toxicol       Date:  2020-07-31       Impact factor: 3.739

Review 10.  Acquired von Willebrand syndrome associated with left ventricular assist device.

Authors:  Angelo Nascimbene; Sriram Neelamegham; O H Frazier; Joel L Moake; Jing-Fei Dong
Journal:  Blood       Date:  2016-05-03       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.